Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine approaches for patients across the world. Servier...
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies SUZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Vivatides Therapeutics, a global biotechnology company focused on developing extrahepatic...
EICMA 2025: A RECORD-BREAKING EDITION, COMBINING PASSION, BUSINESS, NEW CONTENT, AND NEW WAYS TO GET TO THE SHOW
The 82nd International Two-Wheeler Exhibition closes with more than 600,000 visitors. Growth in international operators, public, media, countries represented, and special initiatives: MotoLive celebrates twenty years with races featuring motorsport...